776.0000 17.45 (2.30%)
NSE Jul 04, 2025 15:31 PM
Volume: 3.2M
 

776.00
2.30%
ICICI Securities Limited
Q3 results were above I-direct estimates on all fronts. Laurus is well poised to follow the success story of some leading CDMO players backed by strong chemistry and integrated model. Elsewhere, formulations are expected to grow amid ramp up and new launches (e.g. TLE400) in LMIC and launches in the US. Other APIs are expected to be driven by a strong order book and capacity addition. Besides continuous improvement in the financial performances, the company is evolving as a strong vertically integrated player with strong order book visibility, improving margin profile,...
Laurus Labs Ltd. has gained 26.85% in the last 6 Months
More from Laurus Labs Ltd.
Recommended